Guangzhou Sinogen Pharmaceutical Co., Ltd

This study tests a modified salmonella bacteria (SGN1) injected directly into tumors in people with advanced solid cancers that haven't responded to standard treatments. The bacteria are designed to grow inside tumors and cut off their food supply (an amino acid called methionine…

This study is testing a modified salmonella bacteria (SGN1) designed to grow inside tumors and cut off their food supply, potentially shrinking or slowing them. It is for people with advanced solid tumors that have not responded to other treatments. The trial will first check saf…